Although postmenopausal breast cancer (BC) risk has been linked to adiposity, associations between adiposity and premenopausal BC remain unclear. To address this question, we investigated the association of BC risk with measures of adiposity, including body mass index (BMI) and waist circumference (WC), in a large cohort of Asian women. We used a nationwide cohort of adult Korean women selected from the National Health Insurance Corporation database merged with national health examination data from 2009 to 2015. A total of 11,227,948 women were tracked to retrospectively identify incident cases of BC. Our analysis used Cox proportional hazards models to calculate hazard ratios and assess the association of BC risk with BMI and/or WC in both pre-and postmenopausal women. BMI and WC were robustly associated with increased risk for postmenopausal BC (p trend <0.001 for both BMI and WC) but not with premenopausal BC. Association between WC and premenopausal BC was only statistically significant when considering BMI (p trend 50.044). In contrast, postmenopausal BC was negatively associated with WC when considering BMI (p trend 50.011). In premenopausal women, WC may predict increased BC risk when considering BMI. However, in postmenopausal women, WC is not superior to BMI as an indicator of BC risk.
Introduction
Breast cancer (BC) is the second most common cancer worldwide and accounts for approximately 25% of all cancer in women. 1 The study of BC is especially relevant in Korea, where the prevalence of BC is rapidly increasing with higher fatality rate. 2 Given the socioeconomic burden of BC, identification of actionable risk factors would be benefit public health. Obesity, excess caloric intake and physical inactivity have all been identified as risk factors that can be modified by patient action. 3 In addition, the International Agency for Research on Cancer stated that there is sufficient evidence that the absence of excess body fat has a role in preventing postmenopausal BC. 4 Although there is a large body of evidence to support an association between adult adiposity and incident BC, menopausal status and obesity index are sources of variation and inconsistency. 4 The body mass index (BMI) is a widely used indicator for assessing general adiposity, whereas waist circumference (WC) is used as a measure of visceral fat. Visceral fat is of particular interest in cases of BC, because it releases inflammatory markers that may promote BC development. 5, 6 A positive relationship between general adiposity and postmenopausal BC is well documented, but a dose-response meta-analysis of 30 observational studies reported an inverse association between BMI and premenopausal BC occurrence among Caucasian and African women. However, this analysis found a positive association between BMI and premenopausal BC among Asian women. 7 These ethnic differences were explained by body size and fat composition in Asians as compared to other ethnic groups. 8 Furthermore, a recent systematic review indicated that the central adiposity-BC association may be mediated differently in pre-and postmenopausal women. 9 However, meta-analyses of observational studies have inherent limitations, including publication biases at identification and review levels, as well as limited statistical and clinical heterogeneity. 10 Thus, it remains unclear if a lower WC is an indicator of increased BC risk in premenopausal Asian women. To address this issue, we investigated the association of BMI and/or WC with the risk of BC in pre-and postmenopausal Korean women using a nationwide cohort.
Methods

Data source and study population
The Korean National Health Insurance Corporation (NHIC) provides mandatory universal comprehensive medical care to 97% of Koreans, while the remaining 3% of the population with low economic status are covered by the Medical Aid program. Since 2006, data from Medical Aid beneficiaries have been incorporated into a single NHIC database, which includes enrollee demographics, utilization of medical facilities, disease codes as registered by clinicians and pharmacy dispensing claims. The NHIC also recommends standardized biennial medical examinations, which include measurements of height, weight, blood pressure and fasted serum levels of glucose and total cholesterol. Beginning in 2009, WC has been measured at the umbilicus level by trained experts or nurses. Self-reported medical history and health-related habits, such as smoking, alcohol consumption and physical activity, were surveyed using standardized questionnaires. Quality control procedures were in accordance with the Korean Association of Laboratory Quality Control.
For our study, we selected the examination closest to January 1, 2009 (index date). We used the data from a 7-year cohort (2009) (2010) (2011) (2012) (2013) (2014) (2015) , which were provided by the NHIC for research purposes and handled with high confidentiality. Previously published epidemiologic research has similarly used the NHIC database. 11, 12 From the NHIC records, we selected females, 20 years of age or older who had received a national health examination at least once between 2009 and 2012. From this group, we excluded any individuals who had been diagnosed with any type of cancer before the index date or who were missing WC data. Finally, 11,227,948 women were followed up to the date of a BC diagnosis or to December 31, 2015, whichever came first. Our study was exempt from review by the Korea National Institute for Bioethics Policy (P01-201603-21-005).
Data collection
Newly diagnosed BC was designated as the primary endpoint of our study, indicated by the International Classification of Diseases Code -10th Revision (ICD-10). BC incidence was determined by a registration program for severe and/or rare, intractable diseases, including malignant neoplasm. 13 Within this program, the NHIC provides specific diagnostic criteria to physicians to determine eligibility for copayment reduction, and health institutions are required to review physician diagnoses. Postmenopausal status was assumed after 50 years of age, because this is the usual age for onset of menopause among Korean women.
14 BMI was calculated as weight in kilograms divided by the square of height in meters (kg/m 2 ). Individuals were categorized by BMI into five groups according to the World Health Organization's recommendations for Asians:
What's new? While excess body fat is a risk factor for postmenopausal breast cancer, whether a similar link exists between adiposity and premenopausal breast cancer risk remains uncertain. Here, among Korean women, both body mass index (BMI) and waist circumference were strongly associated with postmenopausal breast cancer risk. BMI was inversely associated with premenopausal breast cancer risk. In all women, BMI adjustment modified associations between waist circumference and breast cancer risk. The findings suggest that unlike postmenopausal breast cancer, where general and central obesity independently predict risk, premenopausal breast cancer risk is predicted by central obesity only when general adiposity is considered. . 15 WC was categorized in intervals of 5 or 10 cm.
Comorbidities were defined primarily by a combination of past history (ICD code and self-reported) and use of one or more drugs for the corresponding disease. Comorbid diseases included hypertension (ICD-10 codes I10-13/15), type 2 diabetes (ICD-10 codes E11-14) and hyperlipidemia (ICD-10 codes E78). Furthermore, individuals who had an abnormal measurement in a health examination, specifically, a blood pressure >140/90 mm Hg, a fasting glucose level >126 mg/ dl or a total cholesterol level >240 mg/dl, were considered to be comorbid for the corresponding disease.
Smoking status was categorized into three groups: never, former and current smoker. Alcohol consumption status was also categorized into three groups: non-, moderate (<30 g per day) and heavy drinkers (30 g per day). Regular physical activity was defined as one exercise session per week.
Statistical analysis
All analyses were performed separately, with analysis groups determined by menopausal status. Multivariate adjusted Cox regression analysis was conducted to calculate hazard ratios (HRs) with a 95% confidence interval (CI) for the association between BC and BMI/WC. Age, health-related habits and comorbidities were included in the model as potential confounding variables. All Cox regression models were tested for and met the proportional hazards assumption. The SAS program (version 9.4 SAS Institute, Cary, NC) was used for all statistics. A twosided p-values <0.05 was considered statistically significant. Table 1 shows the characteristics of participants at baseline according to the menopausal status. Postmenopausal women were more likely to be obese (generally and centrally) and to have favorable health habits and more comorbidities than premenopausal women. Mean follow-up duration was a little over 5 years in both groups.
Results
Fully adjusted regression models were used to detect associations between BMI and BC in pre-and postmenopausal women (Fig. 1) . In premenopausal women, BMI was inversely associated with BC (p trend <0.001), such that premenopausal obese class II women had an 8.6% lower risk for BC, compared to those with a normal weight (95% CI, 0.857-0.974). In postmenopausal women, we found a strong linear relationship between BMI and BC (p trend <0.001). Specifically, postmenopausal obese class II women had a 32.5% higher risk for BC, compared to those with a normal weight (95% CI, 1.263-1.389).
During 59,907,496 person-years of follow up, 74,835 incident cases of BC (37, 192 premenopausal and 37,643 postmenopausal) developed between the beginning of 2009 and end of 2015, resulting in an incidence density of 124.9 cases per 100,000 person-years (Table 2 ). In fully adjusted Cox regression models being adjusted for age, health-related habits and comorbid conditions, WC was associated with postmenopausal BC in a dose-dependent manner (p trend <0.001) but not with premenopausal BC (p trend 50.089). Models being additionally adjusted for BMI revealed a positive trend for the association between WC and premenopausal BC (p trend 50.044). In contrast, postmenopausal BC was negatively associated with WC after adjusting for BMI (p trend 50.011). a Adjusted for age, health-related habits (smoking, alcohol and physical activity) and comorbidities (hypertension, type 2 diabetes and hyperlipidemia).
Discussion
The social burdens of obesity and BC provide a strong incentive to investigate the association between these conditions. In addition, characterization of the effects of adiposity on BC risk may inform BC prevention strategies. This nationwide Asian cohort study aimed to elucidate the influence of general or central adiposity on incident BC, while also considering menopausal status. The main findings were the following: (i) both BMI and WC were strongly associated with increased postmenopausal BC risk; (ii) BMI, but not WC, was inversely associated with BC risk in premenopausal Asian women and (iii) the WC-BC association was notably affected by BMI adjustment, showing different trends in preand postmenopausal women.
Our study confirms previous reports of a positive association between postmenopausal BC and both overall and central adiposity. 4 Adipose tissue is a primary source of estrogen production in postmenopausal women. Thus, body fat mass is directly related to estrogen levels, which encourages cell growth and increases the likelihood of mutations that could lead to BC. 16 Obesity-related metabolic and endocrine abnormalities are also potential mechanisms for increased BC risk, including dysfunctional insulin-like growth factor (IGF) signaling, abnormal adipokine levels and aberrant regulation of inflammatory pathways. 16 The Women's Health Initiative
Observational Studies have suggested that hyperinsulinemia or excess inflammatory mediators, besides estrogen, may play a role in the obesity-postmenopausal BC relationship. 17, 18 In addition, the hypothesis of paracrine role of tumorsurrounding adipose tissue is now increasingly relevant for the development and progression of BC. 19 As a consequence of their crosstalk, adipocytes adjacent to cancer cells display phenotypic and functional alterations, which lead to enhanced invasive properties of tumor cells. 20 In our study, we did not find a positive association between BMI and premenopausal BC risk, and rather we detected an inverse trend. A recent pooled meta-analysis 7 has reported that increased BMI was positively associated with the risk of premenopausal BC among Asian women, in contrast to the inverse association among other ethnicities. These findings were explained by the fact that Asians have greater amounts of fat for a given BMI, compared to other ethnic groups. However, our results did not support the ethnic differences in association between fat density and the risk of premenopausal BC. In addition, of 10 Asian studies included in the previously mentioned meta-analysis, 7 just one study 21 reached a statistical significance on positive association between BMI and premenopausal BC risk.
Evidence for an inverse association between general obesity, measured by BMI and premenopausal BC was weak and was only reached in a meta-analysis. 22 Meta-analyses play an important role in integrating and synthesizing research, but their implication differs according to the design of sources.
23
Whereas meta-analyses of randomized control trials Abbreviations: BMI, body mass index; WC, waist circumference; BC, breast cancer; HR, hazard ratio; CI, confidence interval.
All regression models were adjusted for age, health-related habits (smoking, alcohol and physical activity) and comorbid conditions (hypertension, type 2 diabetes and hyperlipidemia). Significant findings are highlighted in bold.
synthesize the results of several small trials and increase confidence in an observed result, meta-analyses of observational studies explore sources of between-study heterogeneity and identify novel mediators or confounders of an observed effect. 10 For example, a simple pooled meta-analysis 24 of incident BC in Korean women showed that a high BMI was related to a higher incidence of premenopausal BC; however, their dataset included small case-control studies with substantial heterogeneity (e.g., several adjusted variables and a different BMI cut-off value). Furthermore, in a prior nationwide Korean cohort study, BMI was not associated with premenopausal BC risk. 25 In our study, we found that the mediating effect of BMI on the association between WC and BC risk differed between pre-and postmenopausal women, which agreed with a recent systematic review. 9 A possible explanation for the differences between the pre-and postmenopausal groups may be the predominant mechanism by which BC develops before and after menopause. BMI adjustment reversed the association between WC and postmenopausal BC risk, suggesting that general adiposity is more responsible for increased postmenopausal BC risk than central obesity. After menopause, the ovary ceases to produce estrogens and progesterone, and estradiol is continuously produced at extra-gonadal sites such as adipose tissue. 26 This link between postmenopausal estrogen levels and general (not central) adiposity highlights the major contribution of hormonal mechanisms to postmenopausal BC. 27, 28 In contrast, the adiposity-BC association in premenopausal women is more complex. Before menopause, the ovaries produce a homeostatically regulated amount of estrogen, and plasma levels of estrogen are not directly related to general adiposity. 29 In addition, obese premenopausal women are more likely to have anovulatory cycles, because they have lower estradiol levels. 30 Thus, the positive WC-BC association observed in premenopausal women cannot be explained by the sex hormone hypothesis. 31 This conclusion is further supported by the finding that central obesity is associated with an increased risk of estrogen receptor-negative BC in premenopausal women. [32] [33] [34] Metabolic conditions may be more important than hormonal mechanisms in premenopausal BC. Metabolic derangements may influence BC risk via shared signaling pathways. 35, 36 Central adiposity is an independent predictor of hyperinsulinemia and higher levels of IGF-1, which have been found to be related to premenopausal BC risk. 37, 38 Our study has some limitations. First, we assessed only baseline BMI and WC values, and these single measurements may not reflect changes that occur during the follow-up times. In addition, menopausal status is difficult to clearly define, as increasing numbers of premenopausal women entered menopause during the time frame of the study. A prospective study with updates of BMI, WC and menopausal status is needed to confirm the true relationship between these factors. Second, our study did not involve detailed clinical information on patients, such as family history of BC, estrogen or progesterone receptor status, or subtypes of BC. In addition, the use of hormone replacement therapy (HRT) was not examined in our study, as HRT can modify the relationship between obesity and BC risk. However, a systematic review 39 reported that the association between central obesity and BC risk was similar in HRT users and non-users. Despite the limitations mentioned, our study has methodological strengths. As a longitudinal nationwide populationbased cohort study, the size of the data set was close to the actual population size of Korean women. Compulsory nationwide health examinations also allowed us to use direct anthropometric measurements. To our knowledge, no other study has used direct measurements of WC in such a large sample size.
In conclusion, whereas both general and central obesity were positively associated with increased postmenopausal BC risk, central obesity was only a predictor of premenopausal BC when general adiposity was taken into account. Beyond simple replication, interventional trials in both pre-and postmenopausal women are needed to provide further insight on obesity-BC risk. 4 In particular, studies in premenopausal women that investigate how BC risk is altered by either reducing central fat or controlling comorbid metabolic conditions would be constructive.
